Semaglutide and Weight Reduction
Semaglutide, a medication initially established to handle diabetes, has actually revealed potential as a weight loss aid. It works by decreasing appetite, therefore minimizing calorie consumption. The normal dose for weight loss is administered weekly.In a stage 3 clinical trial conducted in 2021, it was discovered that administering a weekly 2.4 milligram dosage of Semaglutide caused notable weight reduction.
Wegovy: The First Once-Weekly Medication
Wegovy is the brand name under which Semaglutide is approved for chronic weight management. It is the first once-weekly medication in its class that's FDA-approved to assist with chronic weight management.For ideal results, it is recommended to integrate modifications to diet plan and exercise together with the drug for weight reduction.